Cargando…
Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation
Osteoporosis is a disease that impacts over 200 million people worldwide. Taking into consideration the side effects stemming from medications used to treat this illness, investigators have increased their efforts to develop novel therapeutics for osteoporosis. In a previous study, we demonstrated t...
Autores principales: | Quach, Darin, Parameswaran, Narayanan, McCabe, Laura, Britton, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864341/ https://www.ncbi.nlm.nih.gov/pubmed/31763377 http://dx.doi.org/10.1016/j.bonr.2019.100227 |
Ejemplares similares
-
Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting
por: Collins, Fraser L., et al.
Publicado: (2016) -
Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes
por: Collins, Fraser L., et al.
Publicado: (2019) -
Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor
por: Dore, Maria Pina, et al.
Publicado: (2019) -
One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density
por: Li, Peishun, et al.
Publicado: (2022) -
Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling
por: Thomas, Carissa M., et al.
Publicado: (2012)